Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Equity Ratio (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Equity Ratio for 15 consecutive years, with 0.78 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 9.0% to 0.78 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.78 through Dec 2025, down 9.0% year-over-year, with the annual reading at 0.78 for FY2025, 9.0% down from the prior year.
  • Equity Ratio hit 0.78 in Q4 2025 for Perspective Therapeutics, down from 0.82 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.96 in Q4 2021 to a low of 0.77 in Q4 2023.
  • Historically, Equity Ratio has averaged 0.89 across 5 years, with a median of 0.9 in 2023.
  • Biggest five-year swings in Equity Ratio: skyrocketed 50.74% in 2021 and later fell 18.35% in 2023.
  • Year by year, Equity Ratio stood at 0.96 in 2021, then decreased by 1.76% to 0.94 in 2022, then fell by 18.35% to 0.77 in 2023, then rose by 10.96% to 0.85 in 2024, then fell by 9.0% to 0.78 in 2025.
  • Business Quant data shows Equity Ratio for CATX at 0.78 in Q4 2025, 0.82 in Q3 2025, and 0.86 in Q2 2025.